The clinical role of serum cell division control 42 in coronary heart disease

References

• Akyuz A. Exercise and coronary heart disease. Adv Exp Med Biol. 2020;1228:169–179.
   PubMed Web of Science ®Google Scholar
• Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812–16823.
   PubMed Web of Science ®Google Scholar
• Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169–177.
   PubMed Web of Science ®Google Scholar
• Kandaswamy E, Zuo L. Recent advances in treatment of coronary artery disease: role of science and technology. Int J Mol Sci. 2018;19(2):424.
   PubMed Web of Science ®Google Scholar
• Jia S, Liu Y, Yuan J. Evidence in guidelines for treatment of coronary artery disease. Adv Exp Med Biol. 2020;1177:37–73.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Lerman A. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis. 2014;25(8):713–724.
   PubMed Web of Science ®Google Scholar
• Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18(6):331–344.
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
   PubMed Web of Science ®Google Scholar
• Fu J, Liu B, Zhang H, et al. The role of cell division control protein 42 in tumor and non-tumor diseases: a systematic review. J Cancer. 2022;13(3):800–814.
   PubMed Web of Science ®Google Scholar
• Pichaud F, Walther RF, Nunes de Almeida F. Regulation of Cdc42 and its effectors in epithelial morphogenesis. J Cell Sci. 2019;132(10):jcs217869.
   PubMed Web of Science ®Google Scholar
• Ito TK, Yokoyama M, Yoshida Y, et al. A crucial role for CDC42 in senescence-associated inflammation and atherosclerosis. PLoS One. 2014;9(7):e102186.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Y, Gao J, et al. Eva1a ameliorates atherosclerosis by promoting re-endothelialization of injured arteries via Rac1/Cdc42/Arpc1b. Cardiovasc Res. 2021;117(2):450–461.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang W, Wang F. The relationship of blood CDC42 level with Th1 cells, Th17 cells, inflammation markers, disease risk/activity, and treatment efficacy of rheumatoid arthritis. Ir J Med Sci. 2022;191(5):2155–2161.
   PubMed Web of Science ®Google Scholar
• Singh RK, Haka AS, Bhardwaj P, et al. Dynamic actin reorganization and vav/Cdc42-dependent actin polymerization promote macrophage aggregated LDL (low-density lipoprotein) uptake and catabolism. Arterioscler Thromb Vasc Biol. 2019;39(2):137–149.
   PubMed Web of Science ®Google Scholar
• Ding L, Zhang L, Kim M, et al. Akt3 kinase suppresses pinocytosis of low-density lipoprotein by macrophages via a novel WNK/SGK1/Cdc42 protein pathway. J Biol Chem. 2017;292(22):9283–9293.
   PubMed Web of Science ®Google Scholar
• Guo F. RhoA and Cdc42 in T cells: are they targetable for T cell-mediated inflammatory diseases? Precis Clin Med. 2021;4(1):56–61.
   PubMedGoogle Scholar
• Kalim KW, Yang JQ, Li Y, et al. Reciprocal regulation of glycolysis-driven Th17 pathogenicity and regulatory T cell stability by Cdc42. J Immunol. 2018;200(7):2313–2326.
   PubMed Web of Science ®Google Scholar
• Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008;127(1):89–97.
   PubMed Web of Science ®Google Scholar
• He X, Liang B, Gu N. Th17/Treg imbalance and atherosclerosis. Dis Markers. 2020;2020:8821029.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang J, Xia L, et al. Inhibition of CDC42 reduces macrophage recruitment and suppresses lung tumorigenesis in vivo. J Recept Signal Transduct Res. 2021;41(5):504–510.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wu J, Tan G. The relation of circulating cell division cycle 42 expression with Th1, Th2, and Th17 cells, adhesion molecules, and biochemical indexes in coronary heart disease patients. Ir J Med Sci. 2022;191(5):2085–2090.
   PubMed Web of Science ®Google Scholar
• Guo J, Li Z, Tang D, et al. Th17/Treg imbalance in patients with severe acute pancreatitis: attenuated by high-volume hemofiltration treatment. Medicine. 2020;99(31):e21491.
   PubMed Web of Science ®Google Scholar
• Greenwood JP, Ripley DP, Berry C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA. 2016;316(10):1051–1060.
   PubMed Web of Science ®Google Scholar
• Cheng X, Ye J, Zhang X, et al. Longitudinal variations of CD. C42 In patients with acute ischemic stroke during 3-year period: correlation with CD4(+) T cells, disease severity, and prognosis. Front Neurol. 2022;13:848933.
   PubMed Web of Science ®Google Scholar
• Broman MT, Mehta D, Malik AB. Cdc42 regulates the restoration of endothelial adherens junctions and permeability. Trends Cardiovasc Med. 2007;17(5):151–156.
   PubMed Web of Science ®Google Scholar
• Sluiter TJ, van Buul JD, Huveneers S, et al. Endothelial barrier function and leukocyte transmigration in atherosclerosis. Biomedicines. 2021;9(4):328.
   PubMed Web of Science ®Google Scholar
• Huang QY, Lai XN, Qian XL, et al. A novel regulator of insulin secretion and diabetes-associated diseases. Int J Mol Sci. 2019;20:Cdc42.
   Web of Science ®Google Scholar
• Yang JQ, Kalim KW, Li Y, et al. Rational targeting Cdc42 restrains Th2 cell differentiation and prevents allergic airway inflammation. Clin Exp Allergy. 2019;49(1):92–107.
   PubMed Web of Science ®Google Scholar
• Tackenberg H, Moller S, Filippi MD, et al. The small GTPase Cdc42 is a major regulator of neutrophil effector functions. Front Immunol. 2020;11:1197.
   PubMed Web of Science ®Google Scholar
• Filatova AY, Potekhina AV, Pylaeva EA, et al. The severity of internal carotid artery stenosis is associated with the circulating Th17 level. Heliyon. 2020;6(5):e03856.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695.
   PubMed Web of Science ®Google Scholar
• Zeitouni M, Clare RM, Chiswell K, et al. Risk factor burden and Long-Term prognosis of patients with premature coronary artery disease. J Am Heart Assoc. 2020;9(24):e017712.
   PubMed Web of Science ®Google Scholar